Combination regimens in EGFR-mutated lung cancer: can we get ORIENT-ed?

导出原文传递

翻译打印收藏纠错

作者： Arielle,Elkrief ^[1] ; Helena,Yu ^[2]

作者单位： Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA. ^[1] Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: yuh@mskcc.org. ^[2]

主题词癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);人类(Humans);肺肿瘤(Lung Neoplasms);突变(Mutation);蛋白激酶抑制剂(Protein Kinase Inhibitors)

DOI 10.1016/S1470-2045(22)00449-1

PMID 35908559

发布时间 2022-09-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交